Prior to joining the company, Dr. Hall served as senior vice president and global head of R&D at Valeant Pharmaceuticals International, where she led the company's product pipeline and life cycle management activities with responsibility for quality compliance. Dr. Hall has also held various leadership roles in R&D at GlaxoSmithKline including clinical pharmacology, project management, medical affairs, and regulatory affairs.
"We are thrilled that Sue has joined the Endo team as the progression of Endo to a leading specialty healthcare company continues," said Rajiv De Silva, president and chief executive officer of Endo. "Sue brings more than 30 years of extensive multi-disciplinary and international expertise in drug development and life cycle management across a broad range of therapeutic areas along with extensive experience in quality. R&D will continue to be a key part of Endo's future organic growth plans and Sue's experience and background make her an excellent fit for the role."